Emergency department screening reveals declining HCV viraemia but stable HBV prevalence in Western Europe: A sentinel surveillance opportunity

dc.contributor.authorVargas Accarino, Elena
dc.contributor.authorRuf, Murad
dc.contributor.authorTownsend, Liam
dc.contributor.authorCasado Martin, Marta
dc.contributor.authorRuiz Cobo, Juan Carlos
dc.contributor.authorLlopis Roca, Ferran
dc.contributor.authorButi, Maria
dc.date.accessioned2026-07-03T11:14:42Z
dc.date.available2026-07-03T11:14:42Z
dc.date.issued2026-03-19
dc.date.updated2026-05-22T13:01:08Z
dc.description.abstractBackground: The World Health Organization targets the elimination of viral hepatitis as a public health threat by 2030, requiring scalable strategies for hepatitis B (HBV) and C (HCV), especially in underserved populations. Emergency departments (EDs) offer a key setting for opt-out blood-borne virus screening, enabling early diagnosis and monitoring of elimination effort s. Methods: We reviewed Western European ED-based HCV and HBV screening studies (2005-2025), including HCV antibody (Ab) positivity with confirmatory HCV-RNA testing and/or HBV surface antigen (HBsAg) positivity. Temporal trends in HCV-RNA + /Ab + and HBsAg prevalence were analyzed across countries. Results: Seventeen HCV studies from five countries (1500,659 individuals) identified 26,081 HCV Ab + and 4347 HCV-RNA + cases. Weighted viremic HCV prevalence declined from 56% in the pre-DAA era (2008-2015) to 10% in 2022-2024, consistently in Spain, England, and Ireland. Ten HBV studies (1425,954 individuals) showed stable HBsAg prevalence (0.70%). Conclusion: ED-based screening reflects population-level changes in viral hepatitis. The decline in viremic HCV highlights the impact of DAA access, while stable HBV prevalence underscores unmet therapeutic needs. ED data could function as a low-cost sentinel surveillance system for hepatitis elimination in Europe. (c) 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
dc.format.extent5 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1878-3511
dc.identifier.pmid41864274
dc.identifier.urihttps://hdl.handle.net/2445/230416
dc.language.isoeng
dc.publisherElsevier Ltd.
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.ijid.2026.108575
dc.relation.ispartofInternational Journal of Infectious Diseases, 2026, vol. 167
dc.relation.urihttps://doi.org/10.1016/j.ijid.2026.108575
dc.rightscc by (c) Vargas Accarino, Elena et al., 2026
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationInfeccions per coronavirus
dc.subject.classificationHepatitis vírica
dc.subject.otherCoronavirus infections
dc.subject.otherViral hepatitis
dc.titleEmergency department screening reveals declining HCV viraemia but stable HBV prevalence in Western Europe: A sentinel surveillance opportunity
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1-s2.0-S1201971226002109-main.pdf
Mida:
609.4 KB
Format:
Adobe Portable Document Format